Penumbra, Inc. (PEN) Financials
PEN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 1.6 billion | 377.4 million |
| 2023-09-30 | 1.5 billion | 364.2 million |
| 2023-06-30 | 1.4 billion | 366.0 million |
| 2023-03-31 | 1.4 billion | 370.8 million |
PEN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 32.6 million | 10.8 million |
| 2023-09-30 | 27.5 million | 14.1 million |
| 2023-06-30 | 12.8 million | 12.8 million |
| 2023-03-31 | 9.2 million | 12.8 million |
PEN Net Income
Graph available only for supporters. Become a supporter to see it.
| Date | Net Income |
|---|---|
| 2023-12-31 | 54.2 million |
| 2023-09-30 | 9.2 million |
| 2023-06-30 | 19.0 million |
| 2023-03-31 | 8.6 million |
PEN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 289.2 million | - | 234.3 million |
| 2023-09-30 | 248.9 million | 23.8 million | 228.8 million |
| 2023-06-30 | 221.1 million | 23.9 million | 231.3 million |
| 2023-03-31 | 199.1 million | 24.4 million | 233.5 million |
PEN Shares Outstanding
PEN Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 3.6 million | 21.9 million | 130.0 million | - |
| 2023-09-30 | 3.3 million | 21.0 million | 123.4 million | - |
| 2023-06-30 | 4.3 million | 21.5 million | 127.4 million | - |
| 2023-03-31 | 3.9 million | 20.0 million | 123.1 million | - |
PEN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 284.7 million | 97.7 million |
| 2023-09-30 | 270.9 million | 93.2 million |
| 2023-06-30 | 261.5 million | 94.6 million |
| 2023-03-31 | 241.4 million | 90.3 million |
PEN
Price: $206.06
52 week price:
Earnings Per Share: 2.31 USD
P/E Ratio: 257.58
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Volume: 268800
Ebitda: 1.8 millionMarket Capitalization: 8.7 billion